In 2024, Medicover completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Medicover has also provided a category-level breakdown for 7 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Medicover’s data sources below and access millions more through our Disclosure Search.
In 2024, the total operational greenhouse gas (GHG) emissions of Medicover amounted to 86,782 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Medicover increased by 10.12%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
In 2024, the total Scope 1 emissions of Medicover were 6,020 metric tons of CO₂ equivalent (tCO₂e). a
Since 2020, Medicover's Scope 1 emissions have increased by 22.16%, reflecting a rising long-term trend in Scope 1 emissions over time. a
Compared to the previous year (2023), Medicover's Scope 1 emissions increased by 4.48%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
In 2024, Medicover reported Scope 2 greenhouse gas (GHG) emissions of 62,292 tCO₂e using the market-based method and 80,762 tCO₂e using the location-based method. a
Compared to the previous year (2023), Medicover's Scope 2 emissions (Location-Based) rose by 10.56% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a
In 2024, Medicover reported its Scope 2 emissions using the market-based method and using the location-based method. a
In 2024, Medicover reported 414,186 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2024 disclosure of Medicover includes a breakdown across 7 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
In 2024, Medicover reported total Scope 3 emissions of 414,186 metric tons of CO₂ equivalent (tCO₂e). a
Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment. a
Compared to the previous year (2023), Medicover's Scope 3 emissions increased by 10.97%, suggesting that the company faced challenges in reducing emissions across its value chain. a
In 2024, Medicover reported emissions for 7 out of the 15 Scope 3 categories defined by the GHG Protocol. a
This partial disclosure allows for some insight into the company's indirect impacts.
In 2024, the largest contributors to Medicover's Scope 3 emissions were: a
In 2024, Medicover reported Scope 1 greenhouse gas (GHG) emissions of 6,020 tCO₂e and total revenues of USD 24,216 millions. This translates into an emissions intensity of 0.25 tCO₂e per millions USD. a
In 2024, Medicover reported a Scope 1 emissions intensity of 0.25 tCO₂e per millions USD. Compared to the peer group median of 5.04 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
In 2024, Medicover ranked 4 out of 22 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places Medicover among the top performers, with one of the lowest emissions intensities relative to peers. a
In 2024, Medicover reported a total carbon footprint of 500,968 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 10.82% increase compared to 2023, suggesting a rise in emissions across its operations or value chain. a
The largest contributor to Medicover's total carbon footprint was Scope 3 emissions, accounting for 82.68% of the company's total carbon footprint, followed by Scope 2 emissions at 16.12%. a